Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen's Denosumab Turned Down Again, but It May Not Be as Bad as It Seems
Amgen's Denosumab Turned Down Again, but It May Not Be as Bad as It Seems
Amgen's Denosumab Turned Down Again, but It May Not Be as Bad as It Seems
Submitted by
admin
on October 23, 2009 - 5:26am
Source:
BNET Pharma
News Tags:
FDA
Amgen
Prolia
denosumab
Headline:
Amgen's Denosumab Turned Down Again, but It May Not Be as Bad as It Seems
Do Not Allow Advertisers to Use My Personal information
